Tarsus Pharmaceuticals, Inc. (TARS)
68.36
-2.67
(-3.76%)
USD |
NASDAQ |
Jan 23, 16:00
68.00
-0.36
(-0.53%)
After-Hours: 20:00
Tarsus Pharmaceuticals Total Liabilities (Quarterly): 199.48M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.558B |
| Codexis, Inc. | 85.42M |
| Precigen, Inc. | 129.40M |
| Celcuity, Inc. | 359.04M |
| CEL-SCI Corp. | 12.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 534.56M |
| Shareholders Equity (Quarterly) | 335.08M |
| Debt to Equity Ratio | 0.2462 |
| Current Ratio | 4.286 |
| Net Debt Paydown Yield | -0.08% |